Aytu BioScience (AYTU) Misses Q3 EPS by 53c

Aytu BioScience (NASDAQ: AYTU) reported Q3 EPS of ($0.53). Revenue for the quarter came in at $12.4 million.

For earnings history and earnings-related data on Aytu BioScience (AYTU) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• TechCreate Group faces NYSE American delisting proceedings
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00